𝔖 Bobbio Scriptorium
✦   LIBER   ✦

1146 POSTER Cost-effectiveness of zoledronic acid in the prevention of fractures in postmenopausal women with early breast cancer receiving aromatase inhibitor: Application to the United Kingdom

✍ Scribed by F. Logman; B. Heeg; M.F. Botteman; A.A. Marfatia; B.A. van Hout


Book ID
118625507
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
63 KB
Volume
5
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Effective inhibition of aromatase inhibi
✍ Nigel J. Bundred; Ian D. Campbell; Neville Davidson; Richard H. DeBoer; Holger E πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 158 KB

## Abstract ## BACKGROUND. Letrozole is safe and effective in postmenopausal women with estrogen receptor‐positive early breast cancer, but long‐term aromatase inhibitor use may cause bone loss and increase fracture risk. This study evaluated an immediate or delayed strategy of bone protection the